- Exchange: London
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Vernalis PLC+ Add to Watchlist
VER:LN44.250 GBp 1.250 2.75%
As of 11:35:05 ET on 09/16/2014.
Company Profile for Vernalis PLC (VER)
Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.
Key Executives for Vernalis PLC (VER)
|Ian GarlandChief Executive Officer||David MackneyChief Financial Officer|